Veeva to deliver next generation customer engagement with agentic AI for Roche<\/i><\/p>\n
BARCELONA, Spain \u2014 24 Nov. 2025 \u2014<\/strong> Veeva Systems<\/a> (NYSE: VEEV) today announced that Roche Pharmaceuticals has chosen to extend its partnership with Veeva Systems by adopting Veeva Vault CRM<\/a>.<\/p>\n \u201cRoche and Veeva have partnered for many years,\u201d said Veeva CEO Peter Gassner. \u201cWe are honored to extend our partnership to Vault CRM and bring the next generation of AI-enabled CRM to the global Roche Pharma field teams.\u201d<\/p>\n \u201cWe\u2019re excited to expand our partnership with Veeva by implementing Vault CRM across our global Pharma organization,\u201d said Wafaa Mamilli, Roche\u2019s chief digital and technology officer. \u201cWith data and AI at its core, Vault CRM will help us create more personalized interactions, giving our teams the insights to better support healthcare professionals and the patients they serve.\u201d<\/p>\n Vault CRM is part of the Vault CRM Suite of applications that provides the foundation for commercial execution. Veeva AI<\/a> is agentic AI in the Vault platform and deep, industry-specific AI agents in all Veeva applications. Veeva AI Agents for Vault CRM<\/a> \u2013 Free Text Agent, Voice Agent, Pre-call Agent, and Media Agent \u2013 are planned for availability in December 2025.<\/p>\n About Veeva Systems<\/strong> Veeva Forward-Looking Statements<\/strong> ###<\/center><\/p>\n
\nVeeva delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world\u2019s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation<\/a>, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com\/eu<\/a>.<\/p>\n
\nThis release contains forward-looking statements regarding Veeva\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2025, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.<\/p>\n